Main Menu

Richard Manning publishes commentary on Nature Biotechnology article

July 20, 2018

Partner Richard Manning published a commentary in the Summer issue of Exchange, from the Medical Industry Leadership Institute of Carlson School of Management. His commentary is about an article in Nature Biotechnology: “Just How Good an Investment Is the Biopharmaceutical Sector?” Dr. Manning offers his own thoughts on the profitability of biopharmaceutical discovery. The commentary is here; the Nature Biotechnology article is here.


Jump to Page